HIRSCHMAN ORIN 13D/13G Filings for X4 Pharmaceuticals, Inc. (XFOR)

HIRSCHMAN ORIN 13D and 13G filings for X4 Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
3:17 pm
Purchase		 2021-12-31 13G X4 Pharmaceuticals, Inc.
XFOR		 HIRSCHMAN ORIN 1,531,600
6.200%		 72,700increase
(+4.98%)		 Filing
2021-06-28
7:32 pm
Purchase		 2021-06-16 13G X4 Pharmaceuticals, Inc.
XFOR		 HIRSCHMAN ORIN 1,458,900
6.200%		 1,458,900increase
(New Position)		 Filing